173 related articles for article (PubMed ID: 27638621)
21. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Expert Rev Anticancer Ther; 2002 Apr; 2(2):227-33. PubMed ID: 12113244
[TBL] [Abstract][Full Text] [Related]
22. Tissue factor, angiogenesis and tumour progression.
Bluff JE; Brown NJ; Reed MW; Staton CA
Breast Cancer Res; 2008; 10(2):204. PubMed ID: 18373885
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
Baxi S; Crandall DL; Meier TR; Wrobleski S; Hawley A; Farris D; Elokdah H; Sigler R; Schaub RG; Wakefield T; Myers D
Thromb Haemost; 2008 Apr; 99(4):749-58. PubMed ID: 18392333
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis.
Sahu A; Jha PK; Prabhakar A; Singh HD; Gupta N; Chatterjee T; Tyagi T; Sharma S; Kumari B; Singh S; Nair V; Goel S; Ashraf MZ
EBioMedicine; 2017 Dec; 26():175-186. PubMed ID: 29217135
[TBL] [Abstract][Full Text] [Related]
25. Cytokine and chemokine regulation of venous thromboembolism.
Najem MY; Couturaud F; Lemarié CA
J Thromb Haemost; 2020 May; 18(5):1009-1019. PubMed ID: 32020753
[TBL] [Abstract][Full Text] [Related]
26. New insights into the mechanisms of venous thrombosis.
Mackman N
J Clin Invest; 2012 Jul; 122(7):2331-6. PubMed ID: 22751108
[TBL] [Abstract][Full Text] [Related]
27. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
28. Side effects of anti-angiogenic drugs.
Elice F; Rodeghiero F
Thromb Res; 2012 Apr; 129 Suppl 1():S50-3. PubMed ID: 22682133
[TBL] [Abstract][Full Text] [Related]
29. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
30. Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy.
Watson N; Al-Samkari H
J Thromb Haemost; 2021 Aug; 19(8):1852-1863. PubMed ID: 33928747
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulants versus cancer.
Tieken C; Versteeg HH
Thromb Res; 2016 Apr; 140 Suppl 1():S148-53. PubMed ID: 27067969
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract][Full Text] [Related]
33. Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis.
McDonald AP; Meier TR; Hawley AE; Thibert JN; Farris DM; Wrobleski SK; Henke PK; Wakefield TW; Myers DD
Thromb Res; 2010 Jan; 125(1):72-8. PubMed ID: 19616825
[TBL] [Abstract][Full Text] [Related]
34. Erythropoiesis stimulating agents, thrombosis and cancer.
Barbera L; Thomas G
Radiother Oncol; 2010 Jun; 95(3):269-76. PubMed ID: 20219259
[TBL] [Abstract][Full Text] [Related]
35. Unexpected pulseless disease associated with recurrent venous thromboembolisms.
Morelle J; Tintillier M; Martinot JB; Moortgat S; Hermans C
Clin Appl Thromb Hemost; 2009; 15(2):239-40. PubMed ID: 18160606
[TBL] [Abstract][Full Text] [Related]
36. The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology.
Winter PC
Hematol Oncol; 2006 Sep; 24(3):126-33. PubMed ID: 16783843
[TBL] [Abstract][Full Text] [Related]
37. Management of thrombosis in the cancer patient.
Andrea N; Ansell J
J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
[TBL] [Abstract][Full Text] [Related]
38. [Actual questions about the prevention of venous thromboembolism in cancer patients receiving chemotherapy].
Losonczy H; Nagy Á; Tar A
Orv Hetil; 2016 Feb; 157(6):203-11. PubMed ID: 27120721
[TBL] [Abstract][Full Text] [Related]
39. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.
Langer F; Bokemeyer C
Hamostaseologie; 2012; 32(2):95-104. PubMed ID: 21792469
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
